Avoro Capital Advisors’s Kura Oncology KURA Stock Holding History

Avoro Capital Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,250,000	Closed	-$19.6M	–	37
2024 Q4	$19.6M	Sell	2,250,000 -1,291,505	-36%	-$18.6M	0.28%	36
2024 Q3	$69.2M	Hold	3,541,505	–	–	1.01%	22
2024 Q2	$72.9M	Sell	3,541,505 -308,495	-8%	-$6.34M	0.97%	25
2024 Q1	$82.1M	Buy	3,850,000 +870,000	+29%	+$16.9M	0.96%	24
2023 Q4	$42.9M	Hold	2,980,000	–	–	0.59%	24
2023 Q3	$27.2M	Sell	2,980,000 -125,000	-4%	-$1.27M	0.42%	27
2023 Q2	$32.9M	Hold	3,105,000	–	–	0.45%	28
2023 Q1	$38M	Hold	3,105,000	–	–	0.56%	24
2022 Q4	$38.5M	Sell	3,105,000 -420,000	-12%	-$6.11M	0.58%	26
2022 Q3	$48.2M	Sell	3,525,000 -1,275,000	-27%	-$19.7M	0.89%	20
2022 Q2	$88M	Hold	4,800,000	–	–	1.74%	15
2022 Q1	$77.2M	Buy	4,800,000 +800,000	+20%	+$11.6M	1.41%	17
2021 Q4	$56M	Hold	4,000,000	–	–	0.95%	18
2021 Q3	$74.9M	Sell	4,000,000 -140,000	-3%	-$2.64M	1.18%	19
2021 Q2	$86.3M	Buy	4,140,000 +140,000	+4%	+$3.48M	1.5%	17
2021 Q1	$113M	Hold	4,000,000	–	–	1.95%	14
2020 Q4	$131M	Buy	4,000,000 +1,565,000	+64%	+$55M	2.25%	14
2020 Q3	$74.6M	Buy	2,435,000 +1,385,000	+132%	+$30.6M	1.06%	21
2020 Q2	$17.1M	Buy	+1,050,000	New	+$15.1M	0.34%	35

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avoro Capital Advisors's KURA Position: Q1 2025 in Review

Avoro Capital Advisors sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 2,250,000 shares — an estimated $19.6M sold.

Avoro Capital Advisors first reported a position in KURA in Q2 2020 and held it in 19 quarters. The position peaked at $131M in Q4 2020. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

Avoro Capital Advisors reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
Avoro Capital Advisors sold 2,250,000 Kura Oncology shares in Q1 2025, an estimated $19.6M.
Avoro Capital Advisors first reported a position in Kura Oncology in Q2 2020 and held it in 19 quarters.
Avoro Capital Advisors's Kura Oncology position peaked at $131M in Q4 2020.
183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on Avoro Capital Advisors's 13F filing for Q1 2025, filed 15 May 2025.